Clinical Trial Update: Blood Lipopolysaccharide (LPS) Rifaximin Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a rifaximin/LPS study in obese individuals with insulin resistance; trial completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome
• Obesity

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Philip Kern | Conditions: Obese, Insulin Resistance | Phase 2 | Status: COMPLETED | Results posted: 2019-08-21